PHEOPHORBIDE A

ID: ALA510103

Max Phase: Preclinical

Molecular Formula: C35H36N4O5

Molecular Weight: 592.70

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=Cc1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)[C@@H]4C(=O)OC)[C@@H](CCC(=O)O)[C@@H]3C

Standard InChI:  InChI=1S/C35H36N4O5/c1-8-19-15(3)22-12-24-17(5)21(10-11-28(40)41)32(38-24)30-31(35(43)44-7)34(42)29-18(6)25(39-33(29)30)14-27-20(9-2)16(4)23(37-27)13-26(19)36-22/h8,12-14,17,21,31,36,39H,1,9-11H2,2-7H3,(H,40,41)/b22-12-,23-13-,24-12-,25-14-,26-13-,27-14-,32-30-/t17-,21-,31+/m0/s1

Standard InChI Key:  NSFSLUUZQIAOOX-QEWKCGBTSA-N

Associated Targets(Human)

KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
1A9 (618 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL (619 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-8 (3484 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCG2 Tchem ATP-binding cassette sub-family G member 2 (4927 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOX1.4 Seed linoleate 9S-lipoxygenase (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 592.70Molecular Weight (Monoisotopic): 592.2686AlogP: 7.12#Rotatable Bonds: 6
Polar Surface Area: 138.03Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.61CX Basic pKa: 5.01CX LogP: 5.52CX LogD: 3.78
Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.20Np Likeness Score: 1.45

References

1. Cheng HH, Wang HK, Ito J, Bastow KF, Tachibana Y, Nakanishi Y, Xu Z, Luo TY, Lee KH..  (2001)  Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.,  64  (7): [PMID:11473423] [10.1021/np000595b]
2. Zhang HJ, Tan GT, Hoang VD, Hung NV, Cuong NM, Soejarto DD, Pezzuto JM, Fong HH..  (2003)  Natural anti-HIV agents. Part IV. Anti-HIV constituents from Vatica cinerea.,  66  (2): [PMID:12608862] [10.1021/np020379y]
3. You H, Yoon HE, Yoon JH, Ko H, Kim YC..  (2011)  Synthesis of pheophorbide-a conjugates with anticancer drugs as potential cancer diagnostic and therapeutic agents.,  19  (18): [PMID:21873067] [10.1016/j.bmc.2011.07.058]
4. Pan W, Liu K, Guan Y, Tan GT, Hung NV, Cuong NM, Soejarto DD, Pezzuto JM, Fong HH, Zhang H..  (2014)  Bioactive compounds from Vitex leptobotrys.,  77  (3): [PMID:24404757] [10.1021/np400779v]
5. Kurihara H, Kagawa Y, Konno R, Kim SM, Takahashi K..  (2014)  Lipoxygenase inhibitors derived from marine macroalgae.,  24  (5): [PMID:24495846] [10.1016/j.bmcl.2014.01.046]
6. Krapf MK, Gallus J, Vahdati S, Wiese M..  (2018)  New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold.,  61  (8): [PMID:29547272] [10.1021/acs.jmedchem.7b01012]
7. Silbermann K,Li J,Namasivayam V,Baltes F,Bendas G,Stefan SM,Wiese M.  (2020)  Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-Spectrum ABCB1, ABCC1, and ABCG2 Antagonists.,  63  (18): [PMID:32787102] [10.1021/acs.jmedchem.0c00961]

Source